US to Send Ebola-Exposed Americans to Kenya in Policy Shift

The Trump administration has decided to send American citizens exposed to the Ebola virus to Kenya for quarantine and treatment, rather than repatriating them to the United States — a significant departure from decades of established protocol during previous Ebola outbreaks, according to The New York Times.

The decision comes amid a rapidly escalating Ebola outbreak in Central and East Africa caused by the rare Bundibugyo virus strain, which has already infected more than 1,000 people and claimed over 260 lives since it was first confirmed on 14 May 2026.

A Break from Past Practice

During previous Ebola outbreaks, health care workers and other U.S. citizens exposed to the virus were brought home to be treated at specialized medical units in the United States. The current approach marks a sharp departure from that precedent.

According to three people with knowledge of the plans, the administration intends to establish a facility in Kenya — pending approval from the Kenyan government — that will provide both quarantine and treatment capabilities for Americans exposed to or infected with Ebola. The facility will be staffed by officers from the U.S. Public Health Service Commissioned Corps, a uniformed branch under the Department of Health and Human Services.

A Kenyan foreign affairs ministry spokesperson said the government was “in the process of verifying reports” of the facility being set up there, as The EastAfrican reported via Reuters.

Earlier this month, the administration flew an American doctor, Peter Stafford, who developed Ebola symptoms to a hospital in Germany, and transported six other Americans for monitoring in Germany and the Czech Republic. The initial plan was to monitor exposed Americans in Kenya and transfer anyone who developed symptoms to Europe; that plan has since expanded to include full treatment capabilities in Kenya.

The Outbreak Context

The 2026 Central Africa Ebola epidemic was declared a Public Health Emergency of International Concern by the World Health Organization on 16 May. The outbreak is caused by the Bundibugyo virus (BDBV), a rare strain for which there is no approved vaccine or specific treatment, according to Wikipedia.

As of 27 May, the outbreak has spread across the Democratic Republic of the Congo and Uganda, with 1,086 suspected cases, 119 confirmed cases, and 264 deaths. The epicenter is in Ituri Province, DRC, an area already grappling with ethnic conflict and a humanitarian crisis affecting 1.9 million people.

This is the 17th Ebola outbreak in the DRC, occurring only five months after the previous outbreak ended. There have been only two previous Bundibugyo outbreaks — in Uganda (2007-2008) and the DRC (2012) — and the virus is estimated to have a fatality rate between 25% and 50%.

Public Health and Diplomatic Concerns

Experts have raised questions about whether a newly established facility in Kenya would be able to match the level of care provided by specialized Ebola treatment units in the United States. The lack of approved vaccines or treatments for the Bundibugyo strain makes all response efforts more challenging.

The U.S. Centers for Disease Control and Prevention has confirmed that no Ebola cases have been detected in the United States and that the risk to the general public remains low. The CDC has asked staff to volunteer for deployment to support Ebola screening at U.S. entry points.

The administration has also invoked Title 42 — a public health law — to bar immigrants and legal permanent residents from the DRC, Uganda, and South Sudan, mirroring its use during the COVID-19 pandemic. All returning U.S. citizens from affected countries must enter via Washington Dulles International Airport.

Broader Implications

The decision unfolds against a backdrop of significant U.S. foreign aid cuts under the Trump administration, including the dismantling of USAID, which critics say has weakened global disease surveillance networks. The Guardian described the United States as “notably absent” in international Ebola response efforts due to these reductions.

The establishment of a U.S.-run medical facility on Kenyan soil also raises questions about sovereignty and jurisdiction. African nations may view the move as the United States outsourcing risk to an African country rather than taking responsibility for its own citizens.

What to Watch For

Key unanswered questions remain: Has the Kenyan government formally approved the facility? What specific location in Kenya is being considered? How many Americans are currently at risk in the affected region? And what legal agreements will govern the U.S.-run facility on Kenyan soil?

As the Bundibugyo outbreak continues to spread, the administration’s policy shift is likely to face continued scrutiny from public health experts, diplomats, and lawmakers alike.